Manchester NHS and the Medicines and Healthcare products Regulatory Agency (MHRA) have launched a new initiative aimed at accelerating patient access to healthcare technologies. The partnership will establish a “Manchester Sandbox” program to test promising innovations within real NHS environments, focusing on safety and practical evidence generation.
Real-world testing of emerging tech
The sandbox will enable innovators, clinicians, and regulators to collaborate earlier in the development process. Technologies can be tested in day-to-day healthcare settings rather than waiting for final approval. The program aims to evaluate devices that improve care and safety, support earlier diagnosis, and reduce pressure on services.
Among the first innovations expected to enter the program are AI-enabled medical devices. These tools are designed to identify patients at greater risk of complications from long-term conditions. By detecting risks earlier, clinicians can intervene sooner and improve outcomes.
This approach attempts to solve a common bottleneck in the healthcare sector. Developers often struggle to prove the effectiveness of their technologies in real clinical environments, even if the tools show promise during development. The sandbox creates a controlled framework with appropriate oversight to generate the evidence needed for wider implementation.
Insights generated through the initiative will be shared across the NHS. This helps organisations make informed decisions about which technologies deliver measurable benefits. The program also helps technology developers understand the evidence requirements for broader deployment.
Related: UK Increases Ebola Aid Amid Congo Outbreak Surge
Partnership and expansion plans
Local leaders and representatives from the MHRA and Manchester University NHS Foundation Trust (MFT) attended the launch event at MFT’s Oxford Road Campus, one of Europe’s largest academic health campuses. Attendees saw demonstrations of emerging technologies, including wearable health devices and AI-powered Ambient Voice Technology solutions.
The MHRA will invite expressions of interest from medical device developers wishing to participate in the next phase of the program. Later this year, MFT and the agency will host a roundtable bringing together healthcare providers, researchers, innovators, patient representatives, and regulators.
Minister for Health Innovation James Frith emphasized the balance between innovation and safety. He noted that the partnership will test new technologies in real NHS settings with strict oversight and guardrails. The goal is to identify what works in a carefully controlled way.
Manchester continues to position itself as a leading center for healthcare innovation. The region combines a large NHS trust with research expertise and digital infrastructure. The initiative builds on partnerships between NHS organisations, universities, researchers, regulators, and technology developers across Greater Manchester.
